FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087079946> ?p ?o ?g. }

• W3087079946 endingPage "1741" @default.
• W3087079946 startingPage "1741" @default.
• W3087079946 abstract "Tumor size larger than 4 cm is accepted as an indication for adjuvant chemotherapy in patients with node-negative non-small cell lung cancer (NSCLC). Treatment guidelines suggest that high-risk features are also associated with the efficacy of adjuvant chemotherapy among patients with early-stage NSCLC, yet this association is understudied.To assess the association between adjuvant chemotherapy and survival in the presence and absence of high-risk pathologic features in patients with node-negative early-stage NSCLC.This retrospective cohort study using data from the National Cancer Database included 50 814 treatment-naive patients with a completely resected node-negative NSCLC diagnosed between January 1, 2010, and December 31, 2015. The study was limited to patients who survived at least 6 weeks after surgery (ie, estimated median time to initiate adjuvant chemotherapy after surgery) to mitigate immortal time bias. Statistical analysis was performed from December 1, 2018, to February 29, 2020.Adjuvant chemotherapy use vs observation, stratified according to the presence or absence of high-risk pathologic features (visceral pleural invasion, lymphovascular invasion, and high-grade histologic findings), sublobar surgery, and tumor size.The association of high-risk pathologic features with survival after adjuvant chemotherapy vs observation was evaluated using Cox proportional hazards regression models.Overall, 50 814 eligible patients with NSCLC (27 365 women [53.9%]; mean [SD] age, 67.4 [9.5] years]) were identified, including 4220 (8.3%) who received adjuvant chemotherapy and 46 594 (91.7%) who did not receive adjuvant chemotherapy. Among patients with tumors 3 cm or smaller, chemotherapy was not associated with improved survival (hazard ratio [HR], 1.10; 95% CI, 0.96-1.26; P = .17). For patients with tumors larger than 3 cm to 4 cm, adjuvant chemotherapy was associated with a survival benefit among patients who underwent sublobar surgery (HR, 0.72; 95% CI, 0.56-0.93; P = .004). For tumors larger than 4 cm to 5 cm, a survival benefit was associated with adjuvant chemotherapy only in patients with at least 1 high-risk pathologic feature (HR, 0.67; 95% CI, 0.56-0.80; P = .02). For tumors larger than 5 cm, adjuvant chemotherapy was associated with a survival benefit irrespective of the presence of high-risk pathologic features (HR, 0.75; 95% CI, 0.61-0.91; P = .004).In this cohort study, tumor size alone was not associated with improved efficacy of adjuvant chemotherapy in patients with early-stage (node-negative) NSCLC. High-risk clinicopathologic features and tumor size should be considered simultaneously when evaluating patients with early-stage NSCLC for adjuvant chemotherapy." @default.
• W3087079946 created "2020-09-25" @default.
• W3087079946 creator A5000485049 @default.
• W3087079946 creator A5001943409 @default.
• W3087079946 creator A5024946293 @default.
• W3087079946 creator A5028192791 @default.
• W3087079946 creator A5047580298 @default.
• W3087079946 creator A5063268337 @default.
• W3087079946 creator A5068529118 @default.
• W3087079946 creator A5090487857 @default.
• W3087079946 date "2020-11-01" @default.
• W3087079946 modified "2023-10-18" @default.
• W3087079946 title "Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non–Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features" @default.
• W3087079946 cites W1078245714 @default.
• W3087079946 cites W1740332796 @default.
• W3087079946 cites W1774507721 @default.
• W3087079946 cites W1980521948 @default.
• W3087079946 cites W1983672215 @default.
• W3087079946 cites W1994680848 @default.
• W3087079946 cites W2005939863 @default.
• W3087079946 cites W2022799589 @default.
• W3087079946 cites W2025577038 @default.
• W3087079946 cites W2057604474 @default.
• W3087079946 cites W2062494466 @default.
• W3087079946 cites W2065974896 @default.
• W3087079946 cites W2104504726 @default.
• W3087079946 cites W2114855342 @default.
• W3087079946 cites W2117994949 @default.
• W3087079946 cites W2119424848 @default.
• W3087079946 cites W2127342594 @default.
• W3087079946 cites W2136839015 @default.
• W3087079946 cites W2140246622 @default.
• W3087079946 cites W2153169173 @default.
• W3087079946 cites W2158234609 @default.
• W3087079946 cites W2161599528 @default.
• W3087079946 cites W2168374769 @default.
• W3087079946 cites W2521657898 @default.
• W3087079946 cites W2592783575 @default.
• W3087079946 cites W2605560531 @default.
• W3087079946 cites W2606390443 @default.
• W3087079946 cites W2607970143 @default.
• W3087079946 cites W2901122753 @default.
• W3087079946 cites W2915047219 @default.
• W3087079946 cites W2941100792 @default.
• W3087079946 cites W2947436142 @default.
• W3087079946 cites W3018565988 @default.
• W3087079946 cites W4207058970 @default.
• W3087079946 cites W4213097104 @default.
• W3087079946 cites W4233124781 @default.
• W3087079946 cites W4243550142 @default.
• W3087079946 cites W4252054771 @default.
• W3087079946 doi "https://doi.org/10.1001/jamaoncol.2020.4232" @default.
• W3087079946 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7499246" @default.
• W3087079946 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32940636" @default.
• W3087079946 hasPublicationYear "2020" @default.
• W3087079946 type Work @default.
• W3087079946 sameAs 3087079946 @default.
• W3087079946 citedByCount "49" @default.
• W3087079946 countsByYear W30870799462021 @default.
• W3087079946 countsByYear W30870799462022 @default.
• W3087079946 countsByYear W30870799462023 @default.
• W3087079946 crossrefType "journal-article" @default.
• W3087079946 hasAuthorship W3087079946A5000485049 @default.
• W3087079946 hasAuthorship W3087079946A5001943409 @default.
• W3087079946 hasAuthorship W3087079946A5024946293 @default.
• W3087079946 hasAuthorship W3087079946A5028192791 @default.
• W3087079946 hasAuthorship W3087079946A5047580298 @default.
• W3087079946 hasAuthorship W3087079946A5063268337 @default.
• W3087079946 hasAuthorship W3087079946A5068529118 @default.
• W3087079946 hasAuthorship W3087079946A5090487857 @default.
• W3087079946 hasBestOaLocation W30870799461 @default.
• W3087079946 hasConcept C121608353 @default.
• W3087079946 hasConcept C126322002 @default.
• W3087079946 hasConcept C141071460 @default.
• W3087079946 hasConcept C143998085 @default.
• W3087079946 hasConcept C146357865 @default.
• W3087079946 hasConcept C151730666 @default.
• W3087079946 hasConcept C167135981 @default.
• W3087079946 hasConcept C2776256026 @default.
• W3087079946 hasConcept C2776694085 @default.
• W3087079946 hasConcept C2777982462 @default.
• W3087079946 hasConcept C2778740770 @default.
• W3087079946 hasConcept C2779013556 @default.
• W3087079946 hasConcept C50382708 @default.
• W3087079946 hasConcept C71924100 @default.
• W3087079946 hasConcept C72563966 @default.
• W3087079946 hasConcept C86803240 @default.
• W3087079946 hasConceptScore W3087079946C121608353 @default.
• W3087079946 hasConceptScore W3087079946C126322002 @default.
• W3087079946 hasConceptScore W3087079946C141071460 @default.
• W3087079946 hasConceptScore W3087079946C143998085 @default.
• W3087079946 hasConceptScore W3087079946C146357865 @default.
• W3087079946 hasConceptScore W3087079946C151730666 @default.
• W3087079946 hasConceptScore W3087079946C167135981 @default.
• W3087079946 hasConceptScore W3087079946C2776256026 @default.
• W3087079946 hasConceptScore W3087079946C2776694085 @default.
• W3087079946 hasConceptScore W3087079946C2777982462 @default.
• W3087079946 hasConceptScore W3087079946C2778740770 @default.

• next